Peter Feinberg, Director at Immuneering Corp (IMRX), bought 7,500 shares at $7.03 ($53K) on 2025-09-30, disclosed to the SEC on 2025-10-01.
Open-market purchase of $53k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| IMRX | BUY | 2025-09-30 | $36K | — | Filing → |
| IMRX | BUY | 2025-06-23 | $127K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $128K | — | Filing → |